Option Care Health forecasts 2026 adjusted EBITDA of $480M-$495M while holding revenue outlook at $5.675B-$5.775B (NASDAQ:OPCH)

seekingalpha.com · 2026-07-29

Option Care Health (OPCH) Q2 2026 earnings call recap: revenue, EBITDA, EPS beat; guidance tightened; CID stabilizing and buybacks rising.

TickrTrends take: Option Care Health's 2026 guidance of 480 to 495 million dollars in adjusted EBITDA against a revenue range of 5675 to 5775 million dollars implies operating margins that investors tracking valuation should monitor for sustainability. TickrTrends currently identifies the stock as undervalued within the Healthcare sector, suggesting the market may not be fully pricing in the earnings power represented by these forward projections. The consistency of revenue guidance alongside EBITDA growth will be a key metric for determining whether the current undervaluation assessment reflects genuine opportunity or market skepticism about execution.

Read the full story at seekingalpha.com →